naltrexone has been researched along with Mental Disorders in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.89) | 18.7374 |
| 1990's | 4 (10.53) | 18.2507 |
| 2000's | 13 (34.21) | 29.6817 |
| 2010's | 15 (39.47) | 24.3611 |
| 2020's | 3 (7.89) | 2.80 |
| Authors | Studies |
|---|---|
| Kalin, NH | 1 |
| Laks, J; Peterkin, A; Weinstein, ZM | 1 |
| Alam, F; Dhadley, S; Roberts, P; Townley, J; Webster, R; Wright, N | 1 |
| Andraka-Christou, B; Attermann, J; Beck, AJ; Buche, J; Cupito, A; Haffajee, RL | 1 |
| De Filippis, S; De Persis, S; De Risio, L; di Giannantonio, M; Di Nicola, M; Janiri, L; Maremmani, AGI; Maremmani, I; Martinotti, G; Pettorruso, M | 1 |
| Worley, J | 1 |
| Barrio Giménez, P; Gual, A; Guardia, J; Ortega, L; Roncero, C; Yuguero, L | 1 |
| Iheanacho, T; Issa, M; Marienfeld, C; Rosenheck, R | 1 |
| Iheanacho, T; Issa, M; Marienfeld, C; Rosenheck, RA | 1 |
| Guloksuz, S; Reutenauer, EL; Srihari, VH; Tek, C | 1 |
| Gianoli, MO; McCarthy, E; Petrakis, I; Ralevski, E | 1 |
| Findling, RL; Ji, NY | 1 |
| Dowling, NA; Lorains, FK; Merkouris, SS | 1 |
| Blokhina, E; Chawarski, M; Desrosiers, A; Krupitsky, E; Schottenfeld, R; Zvartau, E | 1 |
| Coleman, E; Grant, JE; Raymond, NC | 1 |
| Hulse, GK; Ngo, HT; Tait, RJ | 1 |
| Bowe, T; Harris, AH; Humphreys, KN; Kivlahan, DR | 1 |
| Kerkhof, AJ; Roozen, HG; van den Brink, W | 1 |
| Kleber, HD | 1 |
| Alvarez, CE; Bascarán, MT; Bobes, J; Carreño, JE; Díaz, M; Narciso, GI | 1 |
| Ryback, RS | 1 |
| Carroll, K; Levinson, C; Nich, C; Petrakis, IL; Poling, J; Rounsaville, B | 1 |
| Buonopane, A; Petrakis, IL | 1 |
| Arnold-Reed, DE; Hulse, GK; Ngo, HT; Tait, RJ | 1 |
| Arnold-Reed, DE; Bulsara, MK; Gawthorne, G; Holman, CD; Hulse, GK; O'Neil, P; Rodiguez, C; Tait, RJ | 1 |
| McCann, DJ | 1 |
| Bakharev, VD; Tikhomirov, SM | 1 |
| Hoffman, RE; Ostroff, RB; Roth, AS | 1 |
| Bernstein, GA; Cook, EH; Leonard, HL; March, JS; Riddle, MA; Swanson, JM | 1 |
| Fiellin, DA; O'Connor, PG | 1 |
| Buchalter, AJ; DeCaria, CM; Hollander, E | 1 |
| Maxwell, S; Shinderman, MS | 1 |
| Drummond, C | 1 |
| Mackay, AV | 1 |
| Eames, B | 1 |
| Favazza, AR | 1 |
| Santos, EF | 1 |
10 review(s) available for naltrexone and Mental Disorders
| Article | Year |
|---|---|
Current Best Practices for Acute and Chronic Management of Patients with Opioid Use Disorder.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Comorbidity; Disease Management; Drug Overdose; Female; Fentanyl; Harm Reduction; Humans; Male; Mental Disorders; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Practice Guidelines as Topic; Prevalence | 2022 |
Pharmacotherapy for mental health problems in people with intellectual disability.
Topics: Aggression; Anticonvulsants; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cognition; Human Growth Hormone; Humans; Intellectual Disability; Lithium Compounds; Mental Disorders; Methylphenidate; Naltrexone; Narcotic Antagonists; Prader-Willi Syndrome; Psychotropic Drugs; Risperidone | 2016 |
Interventions for comorbid problem gambling and psychiatric disorders: Advancing a developing field of research.
Topics: Acetylcysteine; Antimanic Agents; Antipsychotic Agents; Anxiety Disorders; Behavior Therapy; Bipolar Disorder; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Free Radical Scavengers; Gambling; Humans; Lithium Compounds; Mental Disorders; Motivational Interviewing; Naltrexone; Narcotic Antagonists; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Tobacco Use Disorder | 2016 |
Pharmacologic treatments for heroin and cocaine dependence.
Topics: Buprenorphine; Clonidine; Cocaine-Related Disorders; Comorbidity; Heroin Dependence; Humans; Mental Disorders; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Narcotics | 2003 |
Pharmacotherapy of alcohol use disorders.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Amitriptyline; Antidepressive Agents, Tricyclic; Comorbidity; Disulfiram; Dopamine; Drug Interactions; Ethanol; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Male; Mental Disorders; Naltrexone; Narcotics; Serotonin; Taurine | 2005 |
Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders.
Topics: Buprenorphine; Comorbidity; Delayed-Action Preparations; Drug Administration Schedule; Drug Design; Drug Therapy, Combination; Humans; Mental Disorders; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 2008 |
[Neuropeptide role in the etiology, pathogenesis and clinical aspects of mental diseases].
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Endorphins; Enkephalins; Humans; Mental Disorders; Naloxone; Naltrexone; Nerve Tissue Proteins; Pituitary Hormones; Psychotropic Drugs; Schizophrenia; Substance-Related Disorders; Vasopressins | 1984 |
Anxiolytics, adrenergic agents, and naltrexone.
Topics: Adolescent; Adolescent Psychiatry; Adrenergic Agonists; Anti-Anxiety Agents; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Psychiatry; Clinical Trials as Topic; Depressive Disorder; Humans; Mental Disorders; Naltrexone; Narcotic Antagonists; Treatment Outcome | 1999 |
Pharmacologic treatment of heroin-dependent patients.
Topics: Analgesics, Opioid; Buprenorphine; Counseling; Heroin Dependence; Humans; Mental Disorders; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Physician's Role; Substance Withdrawal Syndrome | 2000 |
Pathological gambling.
Topics: Cognitive Behavioral Therapy; Comorbidity; Diagnosis, Differential; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Male; Mental Disorders; Naltrexone; Narcotic Antagonists; Residential Treatment; Selective Serotonin Reuptake Inhibitors; Self-Help Groups | 2000 |
9 trial(s) available for naltrexone and Mental Disorders
| Article | Year |
|---|---|
A comparison between phase-III trials and a phase-IV study of nalmefene in alcohol use disorder patients. Is there a difference?
Topics: Adult; Alcoholism; Behavior, Addictive; Comorbidity; Female; Humans; Male; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Risk | 2019 |
Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Clinical Protocols; Double-Blind Method; Female; Humans; Male; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Overweight; Psychotic Disorders; Research Design; Schizophrenia; Weight Gain; Weight Loss | 2013 |
Quality of life in veterans with alcohol dependence and co-occurring mental illness.
Topics: Alcohol Abstinence; Alcohol Deterrents; Alcoholism; Analysis of Variance; Brief Psychiatric Rating Scale; Comorbidity; Connecticut; Diagnosis, Dual (Psychiatry); Disulfiram; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Interviews as Topic; Male; Massachusetts; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Placebos; Psychotropic Drugs; Quality of Life; Severity of Illness Index; Treatment Outcome; Veterans | 2014 |
Psychiatric symptoms, quality of life, and HIV status among people using opioids in Saint Petersburg, Russia.
Topics: Adult; Female; HIV Seropositivity; Humans; Male; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Psychiatric Status Rating Scales; Quality of Life; Russia; Substance Abuse, Intravenous; Young Adult | 2017 |
Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence.
Topics: Adult; Ambulatory Care; Biological Availability; Combined Modality Therapy; Comorbidity; Delayed-Action Preparations; Drug Administration Schedule; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Mental Disorders; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Dropouts; Premedication; Psychotherapy; Spain; Treatment Outcome | 2003 |
Naltrexone in the treatment of adolescent sexual offenders.
Topics: Adolescent; Adolescent Behavior; Adult; Antidepressive Agents; Child Abuse, Sexual; Comorbidity; Drug Administration Schedule; Drug Therapy, Combination; Fantasy; Hospitalization; Humans; Leuprolide; Libido; Male; Masturbation; Mental Disorders; Naltrexone; Narcotic Antagonists; Paraphilic Disorders; Prospective Studies; Sex Offenses; Treatment Outcome | 2004 |
Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
Topics: Alcohol Deterrents; Alcoholism; Diagnosis, Dual (Psychiatry); Disulfiram; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Treatment Outcome | 2005 |
Mental health outcomes following naltrexone implant treatment for heroin-dependence.
Topics: Administration, Oral; Adolescent; Adult; Databases, Factual; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Retrospective Studies; Risk Factors; Treatment Outcome; Western Australia | 2007 |
Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.
Topics: Adolescent; Adult; Borderline Personality Disorder; Dose-Response Relationship, Drug; Emotions; Female; Follow-Up Studies; Humans; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Pain Measurement; Recurrence; Self-Injurious Behavior; Treatment Outcome | 1996 |
19 other study(ies) available for naltrexone and Mental Disorders
| Article | Year |
|---|---|
Insights Into Improving Clinical Outcomes Across Psychiatric Disorders and Medical Comorbidities.
Topics: Alcoholism; Anorexia Nervosa; Attention Deficit Disorder with Hyperactivity; Comorbidity; Humans; Mental Disorders; Methadone; Naltrexone; Narcotics; Patient Outcome Assessment; Schizophrenia; Smoking; Varenicline | 2021 |
Optimising opioid substitution therapy in the prison environment.
Topics: Age Factors; Buprenorphine; Comorbidity; Continuity of Patient Care; Delayed-Action Preparations; Drug Administration Schedule; England; Hepatitis C; HIV Infections; Humans; Mental Disorders; Methadone; Naltrexone; Narcotics; Needle Sharing; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons; Quality Improvement; Social Work; Wales | 2019 |
A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.
Topics: Analgesics, Opioid; Attitude of Health Personnel; Buprenorphine; Delayed-Action Preparations; Drug and Narcotic Control; Female; Humans; Insurance Coverage; Insurance, Health; Male; Mental Disorders; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Physicians'; Specialization; United States | 2020 |
Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study.
Topics: Adult; Alcohol-Related Disorders; Alcoholism; Comorbidity; Female; Humans; Male; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists | 2017 |
The Role of Pleasure Neurobiology and Dopamine in Mental Health Disorders.
Topics: Behavior, Addictive; Brain; Dopamine; Humans; Mental Disorders; Naltrexone; Narcotic Antagonists; Neurobiology; Off-Label Use; Pleasure; Psychiatric Nursing; Substance-Related Disorders | 2017 |
Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study.
Topics: Adult; Aged; Alcoholism; Analysis of Variance; Comorbidity; Diagnosis, Dual (Psychiatry); Drug Utilization; Female; Humans; Logistic Models; Male; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Socioeconomic Factors; United States; United States Department of Veterans Affairs; Veterans | 2013 |
Long-acting injectable depot naltrexone use in the Veterans' Health Administration: a national study.
Topics: Alcohol-Related Disorders; Comorbidity; Delayed-Action Preparations; Diagnosis, Dual (Psychiatry); Drug Prescriptions; Drug Utilization; Female; Hospitalization; Humans; Logistic Models; Male; Mental Disorders; Mental Health Services; Middle Aged; Multivariate Analysis; Naltrexone; Narcotic Antagonists; Psychiatric Department, Hospital; Rural Population; Socioeconomic Factors; Substance-Related Disorders; United States; United States Department of Veterans Affairs; Urban Population; Veterans | 2014 |
Naltrexone + bupropion (Mysimba). Too risky for only modest weight loss.
Topics: Anti-Obesity Agents; Blood Pressure; Bupropion; Drug Combinations; Drug Interactions; Humans; Mental Disorders; Naltrexone; Randomized Controlled Trials as Topic; Weight Loss | 2015 |
Augmentation with naltrexone to treat compulsive sexual behavior: a case series.
Topics: Adult; Comorbidity; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Humans; Liver Function Tests; Male; Mental Disorders; Middle Aged; Minnesota; Naltrexone; Narcotic Antagonists; Retrospective Studies; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome | 2010 |
Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance.
Topics: Adult; Australia; Diagnosis, Dual (Psychiatry); Drug Implants; Female; Heroin Dependence; Hospitalization; Humans; Longitudinal Studies; Male; Mental Disorders; Methadone; Naltrexone; Opiate Substitution Treatment; Prevalence | 2011 |
Pharmacotherapy of alcohol use disorders in the Veterans Health Administration.
Topics: Acamprosate; Administration, Oral; Adult; Age Factors; Alcohol Deterrents; Alcoholism; Ambulatory Care; Comorbidity; Delayed-Action Preparations; Disulfiram; Drug Therapy, Combination; Drug Utilization; Female; Humans; Injections, Intramuscular; Male; Mental Disorders; Middle Aged; Naltrexone; Selective Serotonin Reuptake Inhibitors; Sex Factors; Substance Abuse Treatment Centers; Taurine; United States; Veterans | 2010 |
Experiences with an outpatient relapse program (community reinforcement approach) combined with naltrexone in the treatment of opioid-dependence: effect on addictive behaviors and the predictive value of psychiatric comorbidity.
Topics: Adult; Combined Modality Therapy; Community Mental Health Services; Comorbidity; Diagnosis, Dual (Psychiatry); Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Mental Disorders; Methadone; Naltrexone; Narcotic Antagonists; Patient Care Team; Patient Compliance; Patient Dropouts; Psychotherapy; Reinforcement, Psychology; Secondary Prevention | 2003 |
A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
Topics: Administration, Oral; Adult; Cohort Studies; Female; Heroin Dependence; Hospitalization; Humans; Incidence; Male; Medical Record Linkage; Mental Disorders; Naltrexone; Narcotic Antagonists; Risk Factors; Treatment Outcome; Western Australia | 2007 |
Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness.
Topics: Adult; Alcoholism; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Mental Disorders; Naltrexone; Narcotic Antagonists; Prospective Studies; Psychiatric Status Rating Scales; Retrospective Studies | 2000 |
Naltrexone in the treatment of alcohol dependence: what clinicians need to know.
Topics: Alcoholism; Humans; Mental Disorders; Naltrexone; Narcotic Antagonists; Temperance | 2001 |
Psychiatric implications of endorphin research.
Topics: Animals; Avoidance Learning; Behavior, Animal; Chronic Disease; Endorphins; Humans; Mental Disorders; Naloxone; Naltrexone; Rats; Receptors, Opioid; Schizophrenia | 1979 |
Staying off the merry go round: prescribing habits for recovering patients.
Topics: Analgesics; Comorbidity; Disulfiram; Drug Prescriptions; Humans; Hypnotics and Sedatives; Mental Disorders; Naltrexone; Substance-Related Disorders; Tranquilizing Agents | 1990 |
Treatment of patients with self-injurious behavior.
Topics: Fluphenazine; Humans; Intellectual Disability; Mental Disorders; Naltrexone; Self Mutilation | 1990 |
A naturalistic analytic study of veterans using naltrexone in Puerto Rico.
Topics: Humans; Male; Mental Disorders; Naltrexone; Opioid-Related Disorders; Patient Compliance; Patient Dropouts; Puerto Rico; Sexual Behavior; Veterans | 1989 |